FTC backs FDA guidance intended to curtail citizen petition “shenanigans”

December 13, 2018

Outlook for Disgorgement Remedies in the Trump Administration

February 27, 2017

Price discrimination in the pharmaceutical sector: new decision, but plaintiffs face same challenges

October 28, 2015

Outlook for 2015: Antitrust Litigation in the Pharma Industry – More Than Just Actavis Progeny

March 20, 2015

Federal Circuit Revives Certain Sham Petitioning Antitrust Counterclaims in Tyco-Mutual ANDA Litigation

August 26, 2014

Defining “Payments”: The First Post-Actavis Battleground in Pharmaceutical Reverse Payments

May 7, 2014

DOJ and FTC to Shine Spotlight on Analysis of Conditional Pricing Practices Under the Antitrust Laws

May 7, 2014

CT AG Leads Charge to Increase Transparency of Hospital-Physician Acquisitions and Facility Fees

April 21, 2014

Actelion Settles REMS Dispute with Generic Drug Manufacturers

March 6, 2014

NY Attorney General Forges New Ground in Scrutiny of Pharmaceutical Agreements With First-Filer Exclusivity No-Challenge Settlement

February 25, 2014